Levosimendan in early sepsis: When good ideas give poor results

Anesthesia and Analgesia

Volumn 109, Issue 5, 2009, Pages 1367-1369

  De Backer, Daniel ^a   Bracht, Hendrik ^b  

^a ERASME HOSPITAL   (Belgium)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE; LEVOSIMENDAN; NORADRENALIN; CARDIOTONIC AGENT; HYDRAZONE DERIVATIVE; LACTIC ACID; OXYGEN; PYRIDAZINE DERIVATIVE; SIMENDAN;

CAPACITANCE BLOOD VESSEL; CONTINUOUS INFUSION; EDITORIAL; FLUID RESUSCITATION; HEART INDEX; HEART OUTPUT; HEART STROKE VOLUME; HEMODYNAMICS; HUMAN; LACTIC ACIDOSIS; MEAN ARTERIAL PRESSURE; NONHUMAN; PERFUSION PRESSURE; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK; SPLANCHNIC BLOOD FLOW; VASODILATATION; ANIMAL; BLOOD; BLOOD FLOW; BLOOD PRESSURE; BLOOD VOLUME; DRUG EFFECT; FLUID THERAPY; HEART RATE; LIVER CIRCULATION; MULTIMODALITY CANCER THERAPY; NOTE; PATHOPHYSIOLOGY; TIME; VASCULAR RESISTANCE;

ANIMALS; BLOOD PRESSURE; BLOOD VOLUME; CARDIAC OUTPUT; CARDIOTONIC AGENTS; COMBINED MODALITY THERAPY; FLUID THERAPY; HEART RATE; HEMODYNAMICS; HUMANS; HYDRAZONES; LACTIC ACID; LIVER CIRCULATION; OXYGEN; PYRIDAZINES; REGIONAL BLOOD FLOW; SHOCK, SEPTIC; SPLANCHNIC CIRCULATION; TIME FACTORS; VASCULAR RESISTANCE;

EID: 70350716627     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ANE.0b013e3181b9e91a     Document Type: Editorial

References (12)

1. Ruokonen E, Takala J, Uusaro A. Effect of vasoactive treatment on the relationship between mixed venous and regional oxygen saturation. Crit Care Med 1991;19:1365-1369
2. De Backer D, Zhang H, Cherkhaoui S, Borgers M, Vincent JL. Effects of dobutamine on hepato-splanchnic hemodynamics in an experimental model of hyperdynamic endotoxic shock. Shock 2001;15:208-214
3. De Backer D, Creteur J, Noordally O, Smail N, Gulbis B, Vincent JL. Does hepato-splanchnic VO2/DO2 dependency exist in critically ill septic patients? Am J Respir Crit Care Med 1998; 157:1219-1225
4. Usta C, Eksert B, Golbasi I, Bigat Z, Ozdem SS. The role of potassium channels in the vasodilatory effect of levosimendan in human internal thoracic arteries. Eur J Cardiothorac Surg 2006;30:329-332 (Pubitemid 44051932)
5. Barraud D, Faivre V, Damy T, Welschbillig S, Gayat E, Heymes C, Payen D, Shah AM, Mebazaa A. Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharidetreated rabbits: comparison with dobutamine and milrinone. Crit Care Med 2007;35:1376-1382
6. Oldner A, Konrad D, Weitzberg E, Rudehill A, Rossi P, Wanecek M. Effects of levosimendan, a novel inotropic calciumsensitizing drug, in experimental septic shock. Crit Care Med 2001;29:2185-93
7. Dubin A, Murias G, Sottile JP, Pozo M, Baran M, Edul VS, Canales H, Etcheverry G, Maskin B, Estenssoro E. Effects of levosimendan and dobutamine in experimental acute endotoxemia: a preliminary controlled study. Intensive Care Med 2007; 33:485-494
8. Morelli A, De Castro S, Teboul JL, Singer M, Rocco M, Conti G, De Luca L, Di Angelantonio E, Orecchioni A, Pandian NG, Pietropaoli P. Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression. Intensive Care Med 2005;31:638-644
9. Rivers E, Nguyen B, Havstadt S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001;345:1368-1377
10. Cunha-Goncalves D, Perez-de-Sa V, Grins E, Dahm P, Blomquist S. Inotropic support during experimental endotoxemic shock: Part 1. The effects of levosimendan on splanchnic perfusion. Anesth Analg 2009;109:1568-1575
11. Cunha-Goncalves D, Perez-de-Sa V, Larsson A, Thorne J, Blomquist S. Inotropic support during experimental endotoxemic shock: Part 2. A comparison of levosimendan with dobutamine. Anesth Analg 2009;109:1576-1583
12. Takala J. Determinants of splanchnic blood flow. Br J Anaesth 1996;77:50-58